Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin.
about
Obesity genetics in mouse and human: back and forth, and back againSeparating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in ratsDystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression.A lentiviral gene therapy strategy for the in vitro production of feline erythropoietin.Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14.Gene therapy for muscular dystrophy - a review of promising progress.Epigenetic targets in hematopoietic malignancies.Expression of exogenetic enhanced green fluorescent protein in rat endocranium through lentivirus infection.Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropeniamiR-434-3p and DNA hypomethylation co-regulate eIF5A1 to increase AChRs and to improve plasticity in SCT rat skeletal muscle.The aging of elite male athletes: age-related changes in performance and skeletal muscle structure and function.Emerging technologies in the delivery of erythropoietin for therapeutics.Biological pacing by gene and cell therapy.Highly efficient EIAV-mediated in utero gene transfer and expression in the major muscle groups affected by Duchenne muscular dystrophy.Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene.The skin as a biofactory for systemic secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblasts.Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
P2860
Q26782027-8AACD6F2-7211-498D-A8AA-224C71FF959DQ33550771-B2AD1958-FB83-48C3-BB2A-8AA8424CD9EAQ33730444-78887CCA-7099-41BA-A5C2-EFBF1AF67128Q34428085-AA3B92DE-F705-4590-B3CE-47F5E55CEDBAQ34781681-D66A4C3C-99D5-48D3-A8AD-952C28B29B73Q35184730-7E2C92AE-F543-48D5-B1F5-88F815C6410DQ35551110-A4CEE31A-0EA4-4EBE-89C7-3B3BA18D1D32Q35919263-E0B170D6-D072-4BC7-9025-7F2492CE5737Q36401341-98E6E539-D617-42C1-ADEE-62A71E6A43C7Q36675011-8E6D50DB-69E5-4F9B-A057-B6A6759C4909Q37592569-DEF401F4-1129-43D9-89E2-666976DC638CQ37646523-F2DBDFF5-86C6-49C0-985C-AEE9195034A8Q39662392-5773F079-35A1-452E-BC6F-866C93658A2DQ40510706-46EF8225-133D-45CF-8829-C0ABDF6C2B3EQ45859537-4A9466D3-8798-4A8F-A1F8-989FFFDA98D0Q45875820-914C91DB-45CC-408D-800B-9943DBDAEBA5Q45881869-8184F445-8640-43F6-81B3-19171B79917E
P2860
Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Lentivirus administration to r ...... expression of erythropoietin.
@en
Lentivirus administration to r ...... expression of erythropoietin.
@nl
type
label
Lentivirus administration to r ...... expression of erythropoietin.
@en
Lentivirus administration to r ...... expression of erythropoietin.
@nl
prefLabel
Lentivirus administration to r ...... expression of erythropoietin.
@en
Lentivirus administration to r ...... expression of erythropoietin.
@nl
P356
P1433
P1476
Lentivirus administration to r ...... d expression of erythropoietin
@en
P2093
P304
P356
10.1182/BLOOD.V98.3.594
P407
P577
2001-08-01T00:00:00Z